BRAF Comp. Subsequent Testing (2 CNA) (dog)

LABOKLIN Service ID: 517

Indications:

  • Urothelial carcinoma (transitional cell carcinoma) after negative BRAF mutation analysis (V595E).

Material

  • urinary sediment (especially early morning urine; fluid + smear)
  • aspiration cytology (smears)
    biopsies (formalin-fixed)

Method

copy number alteration (CNA)

Species list

dog

Duration

2 - 7 days

Remark

Detection of the copy number alterations (CNAs) 13/19 and 36/19.
Only a positive result is conclusive.
Reasons for negative results:

  • The transitional cell carcinoma is not caused by CNAs 13/19 and 36/19.
  • There were no mutated cells present in the sample.
  • It is not a transitional cell carcinoma.

The test for CNAs is not suitable for prostate carcinomas.
The test cannot be used for cats.